- About Us
- Research & Pipeline
- Investor Centre
- Media Centre
Kazia Therapeutics CEO Dr James Garner was a key speaker at a Finance News Network event in Sydney last week, where he was later by interviewed by FNN.
Dr Garner presented:
“Glioblastoma is a terrible disease… it still has one of the worst outcomes of any cancer,” Dr Garner said. “Sadly, it’s the disease that claimed the life of US Senator John McCain a few months ago, and it’s enormously difficult to treat because although there is a drug therapy available, that therapy only works for about one third of patients.
“We are developing GDC-0084 to target those two thirds of patients who will not benefit from the existing therapy.
“On available evidence, this looks to be a very safe and efficacious drug.”